Gianfranco Puppo

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Francesco Passiglia, Federico Cappuzzo, Oscar Alabiso et al. · British Journal of Cancer · 2018 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer

Francesco Grossi, Carlo Genova, Lucio Crinò et al. · European Journal of Cancer · 2019 · 78 citations

Medicine, Oncology, Cancer Epidemiology +5

Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report

Rossella Bruno, Agnese Proietti, Greta Alì et al. · Oncology Letters · 2017 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

Marzia Del Re, Eleonora Rofi, Carla Cappelli et al. · BMC Cancer · 2019 · 22 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Prevalence of Long COVID Symptoms Related to SARS-CoV-2 Strains

Teresita Aloè, Federica Novelli, Gianfranco Puppo et al. · Life · 2023 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +11